Stocks and Investing
Stocks and Investing
Wed, November 9, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, November 8, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Luca Issi Maintained (BLUE) at Hold with Decreased Target to $8 on, Nov 8th, 2022
Luca Issi of RBC Capital, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $100 to $8 on, Nov 8th, 2022.
Luca has made no other calls on BLUE in the last 4 months.
There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Thursday, August 18th, 2022
- Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $5 on, Friday, August 5th, 2022
These are the ratings of the 2 analyists that currently disagree with Luca
- Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $10 on, Tuesday, September 20th, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $3 on, Friday, August 19th, 2022
Contributing Sources